These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33349520)

  • 1. Risk stratification in pulmonary hypertension associated with interstitial lung disease: The holy grail?
    Beshay S; Sahay S
    J Heart Lung Transplant; 2021 Mar; 40(3):234-235. PubMed ID: 33349520
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension secondary to interstitial lung disease.
    Shlobin OA; Nathan SD
    Expert Rev Respir Med; 2011 Apr; 5(2):179-89. PubMed ID: 21510729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interstitial lung diseases and pulmonary hypertension].
    Hauber HP
    Internist (Berl); 2009 Sep; 50(9):1072, 1074-6, 1078-9. PubMed ID: 19575171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Key features in the management of diffuse interstitial pulmonary disease].
    Fernández DI; Sánchez RP; Moreno AF; Fernández Fabrellas E
    Arch Bronconeumol; 2009; 45 Suppl 3():3-8. PubMed ID: 20116737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in interstitial lung disease.
    Strange C; Highland KB
    Curr Opin Pulm Med; 2005 Sep; 11(5):452-5. PubMed ID: 16093821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.
    Robertson L; Pignone A; Kowal-Bielecka O; Fiori G; Denton CP; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Jun; 64(6):804-7. PubMed ID: 15897302
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to "Risk stratification in PH associated with interstitial lung disease: The Holy Grail?".
    Tello K; Yogeswaran A; Ghofrani A; Gall H
    J Heart Lung Transplant; 2021 Apr; 40(4):317. PubMed ID: 33516604
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary hypertension in interstitial lung disease.
    Nathan SD
    Int J Clin Pract Suppl; 2008 Jul; (160):21-8. PubMed ID: 18720579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension due to interstitial lung disease.
    King CS; Nathan SD
    Curr Opin Pulm Med; 2019 Sep; 25(5):459-467. PubMed ID: 31365380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of Treatment.
    King CS; Shlobin OA
    Chest; 2020 Oct; 158(4):1651-1664. PubMed ID: 32387520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment in severe pulmonary hypertension due to interstitial lung disease.
    Yogeswaran A; Tello K; Faber M; Sommer N; Kuhnert S; Seeger W; Grimminger F; Ghofrani HA; Richter MJ; Gall H
    J Heart Lung Transplant; 2020 Oct; 39(10):1118-1125. PubMed ID: 32690230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 14. Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
    Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M
    Lung; 2020 Jun; 198(3):547-554. PubMed ID: 32206858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary exercise testing the Holy Grail?
    Boutou AK; Pitsiou GG; Argyropoulou P
    Respirology; 2014 Jul; 19(5):621-2. PubMed ID: 24831928
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary veno-occlusive disease, antiphospholipid antibody and pulmonary hypertension in an adolescent.
    Hussein A; Trowitzsch E; Brockmann M
    Klin Padiatr; 1999; 211(2):92-5. PubMed ID: 10407819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease.
    Kato S; Sekine A; Kusakawa Y; Ogura T; Futaki M; Iwasawa T; Kirigaya H; Gyotoku D; Iinuma N; Iguchi K; Nakachi T; Fukui K; Kimura K; Umemura S
    J Cardiovasc Magn Reson; 2015 Feb; 17(1):10. PubMed ID: 25871501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise pulmonary haemodynamic response predicts outcomes in fibrotic lung disease.
    Jose A; King CS; Shlobin OA; Brown AW; Wang C; Nathan SD
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30093570
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary hypertension in interstitial lung disease.
    Polomis D; Runo JR; Meyer KC
    Curr Opin Pulm Med; 2008 Sep; 14(5):462-9. PubMed ID: 18664977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Respiratory Failure in Interstitial Lung Disease Complicated by Pulmonary Hypertension.
    Vahdatpour CA; Darnell ML; Palevsky HI
    Respir Med; 2020 Jan; 161():105825. PubMed ID: 31785507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.